Varicella Zoster Immune Globulin (VZIG) from Germany
VZIG is human immune serum globulin containing antibodies to varicella-zoster virus for post-exposure prophylaxis in immunocompromised patients. It is classified under HTS 3002.12.0030 as human immune blood sera from donors with recent varicella infection or vaccination. Administered intramuscularly within 96 hours of exposure.
Duty Rate — Germany → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Provide evidence of donor VZV seropositivity; FDA lot-by-lot review mandatory
• Ship in validated frozen containers; monitor for freeze-thaw cycles
• Avoid bulk import without U.S. agent registration per plasma rules